
    
      Current treatment approaches for articular cartilage defects have been disappointing and
      clinical results have been variable. However, when using crosslinked hydrogel technologies,
      in vitro findings have shown chondrocyte growth and extra-cellular matrix (ECM) production
      supportive of cartilage production.
    
  